20 (AIDX) Gains from Investment Securities (2024 - 2026)

20 (AIDX) reported Gains from Investment Securities of $352936.0 for Q1 2026, down 88.12% quarter-over-quarter from $3.0 million in Q4 2025.

20 (AIDX) Gains from Investment Securities (2024 - 2026) Analysis & Trends

20 has reported Gains from Investment Securities for 3 years, with the latest figure at $352936.0 in Q1 2026.

  • For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $352936.0; the trailing twelve-month figure through Mar 2026 stood at $352936.0 (changed N/A YoY), and the FY2025 full-year result was $3.0 million, up 288.22% from the prior year.
  • Gains from Investment Securities for Q1 2026 stood at $352936.0, down from $3.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $3.0 million in Q4 2025, with the low at $352936.0 in Q1 2026.
  • Historically, Gains from Investment Securities has averaged $1.4 million across 3 years, with a median of $765000.0 in 2024.
  • The largest YoY upside for Gains from Investment Securities was 288.22% in 2025 against a maximum downside of 288.22% in 2025.
  • 20's Gains from Investment Securities stood at $765000.0 in 2024, then soared by 288.22% to $3.0 million in 2025, then slumped by 88.12% to $352936.0 in 2026.
  • The last three Gains from Investment Securities figures came in at $352936.0 (Q1 2026), $3.0 million (Q4 2025), and $765000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 20 - - 62,884.00

Historic Data

Download Data
DateValue
Mar 31, 2026 352,936.00
Mar 31, 2026 352,936.00
Dec 31, 2025 2.97 Mn
Dec 31, 2025 2.97 Mn
Dec 31, 2024 765,000.00
Dec 31, 2024 765,000.00